Nasdaq

ModeX Therapeutics Establishes Scientific Advisory Board to Enhance Development of Multispecific Antibodies for Complex Diseases

ModeX Therapeutics Inc., an OPKO Health company, announced the formation of a Scientific Advisory Board to support the development of its immunology and oncology pipeline, which includes ...
Yahoo Finance

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Yahoo Finance

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BioWorld

Modex Therapeutics enters license and collaboration with Merck & Co. for EBV vaccine candidate MDX-2201

Modex Therapeutics Inc., an Opko Health Inc. company, has entered into an exclusive worldwide license and collaboration agreement with Merck & Co. Inc., for the development of MDX-2201, Modex's ...
Pharmabiz

ModeX Therapeutics announces formation of scientific advisory board with leaders at the forefront of immunology and oncology drug development

ModeX Therapeutics Inc., an OPKO Health company, announced the creation of a Scientific Advisory Board to provide counsel and insight into the development of ModeX’s immunology and oncology-focused ...